hegf Search Results


90
Merck KGaA hegf
Hegf, supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hegf/product/Merck KGaA
Average 90 stars, based on 1 article reviews
hegf - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Tsang MD Inc actovegin 5% cream and 0.04% hegf
Summary of studies on human epidermal growth factor
Actovegin 5% Cream And 0.04% Hegf, supplied by Tsang MD Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/actovegin 5% cream and 0.04% hegf/product/Tsang MD Inc
Average 90 stars, based on 1 article reviews
actovegin 5% cream and 0.04% hegf - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
PeproTech hegf
Summary of studies on human epidermal growth factor
Hegf, supplied by PeproTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hegf/product/PeproTech
Average 90 stars, based on 1 article reviews
hegf - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Biochrom human epidermal growth factor
Summary of studies on human epidermal growth factor
Human Epidermal Growth Factor, supplied by Biochrom, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human epidermal growth factor/product/Biochrom
Average 90 stars, based on 1 article reviews
human epidermal growth factor - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
ImmunoTools human egf (hegf)
Epidermal growth factor <t>(EGF)</t> does not protect human CD34 + from apoptosis induced by sublethal irradiation. (A) Cord blood-derived human CD34 + cells were treated for 24 and 48 hours (h) with etoposide (1 µg/mL) and different doses of human EGF <t>(hEGF).</t> Apoptosis was measured using AnnexinV/7AAD and specific apoptosis was calculated. Bars represent means±Standard Error of Mean (SEM) of 5 independent experiments. (B) Cord blood-derived human CD34 + cells were cultured for 24 and 48 h in the presence of human EGF and/or cetuximab at indicated concentrations and specific apoptosis was determined. Bars represent means±SEM of 4 independent experiments. (C) Human CD34 + cells were treated with both etoposide and cetuximab, and specific apoptosis was determined 24 h later. Bars represent means±SEM of 3 independent experiments. (D-F) Human CD34 + cells were transplanted into sublethally irradiated Rag2 −/− γc −/− mice. Four weeks later, mice were irradiated with 3 Gy or left untreated. Mice that were irradiated received daily injections of human and/or murine EGF. Eight days after irradiation, mice were sacrificed and % human CD45 + cells was determined in bone marrow (D) and spleen (E). In addition, the proportion of CD34 + immature cells was determined within the human cell population (F). Bars represent means±SEM of 4–7 animals from 5 independent experiments. Mann-Whitney test, * P ≤0.05; ** P ≤0.01; *** P ≤0.001).
Human Egf (Hegf), supplied by ImmunoTools, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human egf (hegf)/product/ImmunoTools
Average 90 stars, based on 1 article reviews
human egf (hegf) - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

hegf  (Lonza)
90
Lonza hegf
Epidermal growth factor <t>(EGF)</t> does not protect human CD34 + from apoptosis induced by sublethal irradiation. (A) Cord blood-derived human CD34 + cells were treated for 24 and 48 hours (h) with etoposide (1 µg/mL) and different doses of human EGF <t>(hEGF).</t> Apoptosis was measured using AnnexinV/7AAD and specific apoptosis was calculated. Bars represent means±Standard Error of Mean (SEM) of 5 independent experiments. (B) Cord blood-derived human CD34 + cells were cultured for 24 and 48 h in the presence of human EGF and/or cetuximab at indicated concentrations and specific apoptosis was determined. Bars represent means±SEM of 4 independent experiments. (C) Human CD34 + cells were treated with both etoposide and cetuximab, and specific apoptosis was determined 24 h later. Bars represent means±SEM of 3 independent experiments. (D-F) Human CD34 + cells were transplanted into sublethally irradiated Rag2 −/− γc −/− mice. Four weeks later, mice were irradiated with 3 Gy or left untreated. Mice that were irradiated received daily injections of human and/or murine EGF. Eight days after irradiation, mice were sacrificed and % human CD45 + cells was determined in bone marrow (D) and spleen (E). In addition, the proportion of CD34 + immature cells was determined within the human cell population (F). Bars represent means±SEM of 4–7 animals from 5 independent experiments. Mann-Whitney test, * P ≤0.05; ** P ≤0.01; *** P ≤0.001).
Hegf, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hegf/product/Lonza
Average 90 stars, based on 1 article reviews
hegf - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Merck & Co human epidermal growth factor (hegf
Epidermal growth factor <t>(EGF)</t> does not protect human CD34 + from apoptosis induced by sublethal irradiation. (A) Cord blood-derived human CD34 + cells were treated for 24 and 48 hours (h) with etoposide (1 µg/mL) and different doses of human EGF <t>(hEGF).</t> Apoptosis was measured using AnnexinV/7AAD and specific apoptosis was calculated. Bars represent means±Standard Error of Mean (SEM) of 5 independent experiments. (B) Cord blood-derived human CD34 + cells were cultured for 24 and 48 h in the presence of human EGF and/or cetuximab at indicated concentrations and specific apoptosis was determined. Bars represent means±SEM of 4 independent experiments. (C) Human CD34 + cells were treated with both etoposide and cetuximab, and specific apoptosis was determined 24 h later. Bars represent means±SEM of 3 independent experiments. (D-F) Human CD34 + cells were transplanted into sublethally irradiated Rag2 −/− γc −/− mice. Four weeks later, mice were irradiated with 3 Gy or left untreated. Mice that were irradiated received daily injections of human and/or murine EGF. Eight days after irradiation, mice were sacrificed and % human CD45 + cells was determined in bone marrow (D) and spleen (E). In addition, the proportion of CD34 + immature cells was determined within the human cell population (F). Bars represent means±SEM of 4–7 animals from 5 independent experiments. Mann-Whitney test, * P ≤0.05; ** P ≤0.01; *** P ≤0.001).
Human Epidermal Growth Factor (Hegf, supplied by Merck & Co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human epidermal growth factor (hegf/product/Merck & Co
Average 90 stars, based on 1 article reviews
human epidermal growth factor (hegf - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Fisher Scientific hegf
Epidermal growth factor <t>(EGF)</t> does not protect human CD34 + from apoptosis induced by sublethal irradiation. (A) Cord blood-derived human CD34 + cells were treated for 24 and 48 hours (h) with etoposide (1 µg/mL) and different doses of human EGF <t>(hEGF).</t> Apoptosis was measured using AnnexinV/7AAD and specific apoptosis was calculated. Bars represent means±Standard Error of Mean (SEM) of 5 independent experiments. (B) Cord blood-derived human CD34 + cells were cultured for 24 and 48 h in the presence of human EGF and/or cetuximab at indicated concentrations and specific apoptosis was determined. Bars represent means±SEM of 4 independent experiments. (C) Human CD34 + cells were treated with both etoposide and cetuximab, and specific apoptosis was determined 24 h later. Bars represent means±SEM of 3 independent experiments. (D-F) Human CD34 + cells were transplanted into sublethally irradiated Rag2 −/− γc −/− mice. Four weeks later, mice were irradiated with 3 Gy or left untreated. Mice that were irradiated received daily injections of human and/or murine EGF. Eight days after irradiation, mice were sacrificed and % human CD45 + cells was determined in bone marrow (D) and spleen (E). In addition, the proportion of CD34 + immature cells was determined within the human cell population (F). Bars represent means±SEM of 4–7 animals from 5 independent experiments. Mann-Whitney test, * P ≤0.05; ** P ≤0.01; *** P ≤0.001).
Hegf, supplied by Fisher Scientific, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hegf/product/Fisher Scientific
Average 90 stars, based on 1 article reviews
hegf - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
PeproTech recombinant hegf
Epidermal growth factor <t>(EGF)</t> does not protect human CD34 + from apoptosis induced by sublethal irradiation. (A) Cord blood-derived human CD34 + cells were treated for 24 and 48 hours (h) with etoposide (1 µg/mL) and different doses of human EGF <t>(hEGF).</t> Apoptosis was measured using AnnexinV/7AAD and specific apoptosis was calculated. Bars represent means±Standard Error of Mean (SEM) of 5 independent experiments. (B) Cord blood-derived human CD34 + cells were cultured for 24 and 48 h in the presence of human EGF and/or cetuximab at indicated concentrations and specific apoptosis was determined. Bars represent means±SEM of 4 independent experiments. (C) Human CD34 + cells were treated with both etoposide and cetuximab, and specific apoptosis was determined 24 h later. Bars represent means±SEM of 3 independent experiments. (D-F) Human CD34 + cells were transplanted into sublethally irradiated Rag2 −/− γc −/− mice. Four weeks later, mice were irradiated with 3 Gy or left untreated. Mice that were irradiated received daily injections of human and/or murine EGF. Eight days after irradiation, mice were sacrificed and % human CD45 + cells was determined in bone marrow (D) and spleen (E). In addition, the proportion of CD34 + immature cells was determined within the human cell population (F). Bars represent means±SEM of 4–7 animals from 5 independent experiments. Mann-Whitney test, * P ≤0.05; ** P ≤0.01; *** P ≤0.001).
Recombinant Hegf, supplied by PeproTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant hegf/product/PeproTech
Average 90 stars, based on 1 article reviews
recombinant hegf - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Sangon Biotech primers hegf-f (bamh i)
Epidermal growth factor <t>(EGF)</t> does not protect human CD34 + from apoptosis induced by sublethal irradiation. (A) Cord blood-derived human CD34 + cells were treated for 24 and 48 hours (h) with etoposide (1 µg/mL) and different doses of human EGF <t>(hEGF).</t> Apoptosis was measured using AnnexinV/7AAD and specific apoptosis was calculated. Bars represent means±Standard Error of Mean (SEM) of 5 independent experiments. (B) Cord blood-derived human CD34 + cells were cultured for 24 and 48 h in the presence of human EGF and/or cetuximab at indicated concentrations and specific apoptosis was determined. Bars represent means±SEM of 4 independent experiments. (C) Human CD34 + cells were treated with both etoposide and cetuximab, and specific apoptosis was determined 24 h later. Bars represent means±SEM of 3 independent experiments. (D-F) Human CD34 + cells were transplanted into sublethally irradiated Rag2 −/− γc −/− mice. Four weeks later, mice were irradiated with 3 Gy or left untreated. Mice that were irradiated received daily injections of human and/or murine EGF. Eight days after irradiation, mice were sacrificed and % human CD45 + cells was determined in bone marrow (D) and spleen (E). In addition, the proportion of CD34 + immature cells was determined within the human cell population (F). Bars represent means±SEM of 4–7 animals from 5 independent experiments. Mann-Whitney test, * P ≤0.05; ** P ≤0.01; *** P ≤0.001).
Primers Hegf F (Bamh I), supplied by Sangon Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primers hegf-f (bamh i)/product/Sangon Biotech
Average 90 stars, based on 1 article reviews
primers hegf-f (bamh i) - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
PeproTech 20 ng/ml hegf
Formulations of media used in this study
20 Ng/Ml Hegf, supplied by PeproTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/20 ng/ml hegf/product/PeproTech
Average 90 stars, based on 1 article reviews
20 ng/ml hegf - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Promega hegf (human epidermal growth factor
Formulations of media used in this study
Hegf (Human Epidermal Growth Factor, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hegf (human epidermal growth factor/product/Promega
Average 90 stars, based on 1 article reviews
hegf (human epidermal growth factor - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

Image Search Results


Summary of studies on human epidermal growth factor

Journal: Cureus

Article Title: Topical Biological Agents as Adjuncts to Improve Wound Healing in Chronic Diabetic Wounds: A Systematic Review of Clinical Evidence and Future Directions

doi: 10.7759/cureus.27180

Figure Lengend Snippet: Summary of studies on human epidermal growth factor

Article Snippet: Tsang et al. (2003) [ ] , , 61 , Actovegin 5% cream and 0.02% hEGF, Actovegin 5% cream, and 0.04% hEGF , Actovegin 5% cream , 12 weeks , Proportion with complete wound healing, Wound healing rate , 20 of 21 patients (95.3%) in the 0.04% (wt/wt) hEGF group achieved complete healing.

Techniques: Control, Cream, Recombinant

Epidermal growth factor (EGF) does not protect human CD34 + from apoptosis induced by sublethal irradiation. (A) Cord blood-derived human CD34 + cells were treated for 24 and 48 hours (h) with etoposide (1 µg/mL) and different doses of human EGF (hEGF). Apoptosis was measured using AnnexinV/7AAD and specific apoptosis was calculated. Bars represent means±Standard Error of Mean (SEM) of 5 independent experiments. (B) Cord blood-derived human CD34 + cells were cultured for 24 and 48 h in the presence of human EGF and/or cetuximab at indicated concentrations and specific apoptosis was determined. Bars represent means±SEM of 4 independent experiments. (C) Human CD34 + cells were treated with both etoposide and cetuximab, and specific apoptosis was determined 24 h later. Bars represent means±SEM of 3 independent experiments. (D-F) Human CD34 + cells were transplanted into sublethally irradiated Rag2 −/− γc −/− mice. Four weeks later, mice were irradiated with 3 Gy or left untreated. Mice that were irradiated received daily injections of human and/or murine EGF. Eight days after irradiation, mice were sacrificed and % human CD45 + cells was determined in bone marrow (D) and spleen (E). In addition, the proportion of CD34 + immature cells was determined within the human cell population (F). Bars represent means±SEM of 4–7 animals from 5 independent experiments. Mann-Whitney test, * P ≤0.05; ** P ≤0.01; *** P ≤0.001).

Journal: Haematologica

Article Title: In vitro and in vivo evaluation of possible pro-survival activities of PGE2, EGF, TPO and FLT3L on human hematopoiesis

doi: 10.3324/haematol.2018.191569

Figure Lengend Snippet: Epidermal growth factor (EGF) does not protect human CD34 + from apoptosis induced by sublethal irradiation. (A) Cord blood-derived human CD34 + cells were treated for 24 and 48 hours (h) with etoposide (1 µg/mL) and different doses of human EGF (hEGF). Apoptosis was measured using AnnexinV/7AAD and specific apoptosis was calculated. Bars represent means±Standard Error of Mean (SEM) of 5 independent experiments. (B) Cord blood-derived human CD34 + cells were cultured for 24 and 48 h in the presence of human EGF and/or cetuximab at indicated concentrations and specific apoptosis was determined. Bars represent means±SEM of 4 independent experiments. (C) Human CD34 + cells were treated with both etoposide and cetuximab, and specific apoptosis was determined 24 h later. Bars represent means±SEM of 3 independent experiments. (D-F) Human CD34 + cells were transplanted into sublethally irradiated Rag2 −/− γc −/− mice. Four weeks later, mice were irradiated with 3 Gy or left untreated. Mice that were irradiated received daily injections of human and/or murine EGF. Eight days after irradiation, mice were sacrificed and % human CD45 + cells was determined in bone marrow (D) and spleen (E). In addition, the proportion of CD34 + immature cells was determined within the human cell population (F). Bars represent means±SEM of 4–7 animals from 5 independent experiments. Mann-Whitney test, * P ≤0.05; ** P ≤0.01; *** P ≤0.001).

Article Snippet: Thawed cells were cultured in serum-free medium supplemented with 10% ES-FBS (Invitrogen), human TPO (50 ng/mL, Immunotools), FLT3L, SCF, IL3 (100 ng/mL each, Immunotools), human EGF (hEGF) (20 or 200 ng/mL Immunotools), PGE2 (10, 25 or 50 μM, Sigma-Aldrich) and/or cytotoxic drugs (etoposide, taxol, tunicamycin; Sigma-Aldrich).

Techniques: Irradiation, Derivative Assay, Cell Culture, MANN-WHITNEY

Formulations of media used in this study

Journal: Cell Death & Disease

Article Title: Hypoxia-cultured human adipose-derived mesenchymal stem cells are non-oncogenic and have enhanced viability, motility, and tropism to brain cancer

doi: 10.1038/cddis.2014.521

Figure Lengend Snippet: Formulations of media used in this study

Article Snippet: GBM complete media (for 276 BTICs) , 96% DMEM/F12 (Invitrogen, 11330-032) 2% Antibiotic/Antimycotic (Sigma, A5955) 2% B27 (Invitrogen, 17504-044) 20 ng/ml hFGF-b (PeproTech, 100-18B) 20 ng/ml hEGF (PeproTech, AF-100-15).

Techniques: Cell Culture